Comment on

• Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.

  Wils JA, Klein HO, Wagener DJ, Bleiberg H, Reis H, Korsten F, Conroy T, Fickers M, Leyvraz S, Buyse M, et al. Wils JA, et al. J Clin Oncol. 1991 May;9(5):827-31. doi: 10.1200/JCO.1991.9.5.827. J Clin Oncol. 1991. PMID: 2016625 Clinical Trial.
• Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

  Webb A, Cunningham D, Scarffe JH, Harper P, Norman A, Joffe JK, Hughes M, Mansi J, Findlay M, Hill A, Oates J, Nicolson M, Hickish T, O'Brien M, Iveson T, Watson M, Underhill C, Wardley A, Meehan M. Webb A, et al. J Clin Oncol. 1997 Jan;15(1):261-7. doi: 10.1200/JCO.1997.15.1.261. J Clin Oncol. 1997. PMID: 8996151 Clinical Trial.
• Standard chemotherapy for gastric carcinoma: is it a myth?

  Ajani JA. Ajani JA. J Clin Oncol. 2000 Dec 1;18(23):4001-3. doi: 10.1200/JCO.2000.18.23.4001. J Clin Oncol. 2000. PMID: 11099333 No abstract available.